<?xml version='1.0' encoding='utf-8'?>
<document id="25199921"><sentence text="Proton pump inhibitors do not impair the effectiveness of metformin in patients with diabetes."><entity charOffset="58-67" id="DDI-PubMed.25199921.s1.e0" text="metformin" /></sentence><sentence text="In order to exert its pharmacodynamic effect, the diabetes drug metformin needs to be taken up into hepatocytes by the organic cation transporter (OCT) system"><entity charOffset="64-73" id="DDI-PubMed.25199921.s2.e0" text="metformin" /></sentence><sentence text=" A recent in vitro study found that proton pump inhibitors (PPIs) inhibit OCT1, OCT2 and OCT3, suggesting that PPIs might reduce metformin's effectiveness" /><sentence text=" This pharmacoepidemiologic study looked for evidence of a clinical effect of such an interaction" /><sentence text="" /><sentence text="This was an observational cohort study examining changes in glycosylated haemoglobin (HbA1c) with exposure to metformin and to PPIs as single agents and in combination"><entity charOffset="110-119" id="DDI-PubMed.25199921.s6.e0" text="metformin" /></sentence><sentence text=" The aim was to assess evidence of a deleterious drug-drug interaction" /><sentence text="" /><sentence text="PPIs did not reduce the effectiveness of metformin, and indeed were associated with a minimally better glycaemic response by - 0"><entity charOffset="41-50" id="DDI-PubMed.25199921.s9.e0" text="metformin" /></sentence><sentence text="06 HbA1c percentage points (95% confidence interval, -0" /><sentence text="10, -0" /><sentence text="01) in metformin initiators"><entity charOffset="7-16" id="DDI-PubMed.25199921.s12.e0" text="metformin" /></sentence><sentence text="" /><sentence text="Despite a mechanistic basis for a potential drug-drug interaction, we found no evidence of a deleterious interaction between PPIs and metformin"><entity charOffset="134-143" id="DDI-PubMed.25199921.s14.e0" text="metformin" /></sentence><sentence text="" /></document>